T80.5XXA Anaphylactic shock due to serum, initial encounter

Name of the Condition

• Anaphylactic shock due to serum, initial encounter.

Summary

This condition describes a severe, life-threatening systemic allergic reaction triggered by exposure to serum, resulting in shock. It is a rapid-onset response affecting multiple organ systems, requiring immediate medical intervention. The "initial encounter" designation indicates this is the first episode or active phase of treatment.

Causes

Anaphylactic shock due to serum occurs when the immune system overreacts to proteins or components in serum, releasing histamine and other mediators. This can result from administration of serum-derived products, such as antivenoms, antitoxins, or immunoglobulins.

Risk Factors

• Prior exposure to serum-containing products
• Known allergies to animal proteins (e.g., horse or rabbit serum)
• History of severe allergic reactions (anaphylaxis)
• Underlying atopic conditions (e.g., asthma, eczema)
• Administration of high-risk products (e.g., antivenoms)

Symptoms

• Sudden onset of hives, itching, or flushing
• Swelling of the lips, tongue, or throat
• Difficulty breathing or wheezing
• Rapid heartbeat or hypotension
• Nausea, vomiting, or abdominal cramps
• Dizziness, fainting, or loss of consciousness

Diagnosis

Diagnosis is based on clinical presentation, including rapid symptom onset after serum exposure, and exclusion of other causes. Healthcare providers assess symptoms, timing, and potential triggers to confirm the reaction. Skin testing or serum-specific IgE testing may be used to identify the allergen, but treatment often precedes testing.

Treatment Options

Immediate treatment includes epinephrine administration, followed by supportive care such as oxygen, intravenous fluids, and antihistamines. Monitoring in a critical care setting is essential. Long-term management may involve avoiding the triggering serum product and carrying an epinephrine auto-injector.

Prognosis and Follow-Up

With prompt treatment, most patients recover fully. Follow-up care includes monitoring for delayed reactions and referral to an allergist for further evaluation. Patients should avoid future exposure to the triggering serum and carry emergency medication as prescribed.

Complications

• Respiratory failure requiring mechanical ventilation
• Cardiovascular collapse
• Brain damage from prolonged hypotension
• Death (rare but possible without immediate intervention)

Lifestyle & Prevention

• Avoid known serum-containing products or derivatives.
• Inform healthcare providers of any history of serum allergies.
• Carry an epinephrine auto-injector if prescribed.
• Wear medical identification (e.g., bracelet) indicating serum allergy.

When to Seek Professional Help

Seek immediate medical attention if symptoms of anaphylaxis occur after serum exposure, including difficulty breathing, swelling, or dizziness. Do not wait for symptoms to worsen.

Tips for Medical Coders

Document the specific serum product involved, the timing of the reaction (initial encounter), and any administered treatments. Ensure the code T80.5XXA is used for the initial episode of anaphylactic shock due to serum. Include details about the clinical presentation and response to intervention for accurate coding and billing.